Tag:

Aragon Pharmaceuticals

Latest Headlines

Latest Headlines

UPDATED: Aragon raises $42M for closely-watched prostate cancer drug

Now that San Diego-based Aragon Pharmaceuticals has wrapped its early-stage work on their anti-androgen prostate cancer drug ARN-509 with some encouraging indications of its impact on tumors, the...

Aragon Pharma readies first cancer trial after $22M B round

Aisling Capital has joined the crew of investors backing San Diego-based start-up Aragon Pharmaceuticals, leading a $22 million Series B that will fuel its pursuit of a clinical trial on a new